Where does Debiotech S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Debiotech S.A. ranks #6,233 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Debiotech S.A. hold?

Debiotech S.A. holds 54 US utility patents granted between 2015 and 2024, spanning 19 technology areas.

What is Debiotech S.A.'s Innovation Score?

Debiotech S.A. has an Innovation Score of 45.5 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Debiotech S.A.'s patent grant rate increasing or decreasing?

Debiotech S.A.'s recent grant velocity is -31% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Debiotech S.A.'s patents?

Debiotech S.A.'s patents average 20.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Debiotech S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Debiotech S.A.

Q: What technology areas does Debiotech S.A. focus on?

Debiotech S.A.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 50 patents, ranking #145 of 3,490 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

USPTO PatentsView assignee record - 54 granted patents across 19 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Debiotech ranks #6,233 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 19 technology areas.

#6,233
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.5/100): 20.9
avg claims per patent: -31%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6233 · Foreign Corporation #6,233 · 54 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 54 grants
UPPER-Q #6,233/49,997
PHOTO-FINISH Comau S p A
CPC-FOCUS A61M · 19 areas
INNOV-PAR 45.5/100
CLAIMS-DENSE 20.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -31% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Comau S.p.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Debiotech’s 45.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (30%) Velocity 3.7 pts (8%) Breadth 15.4 pts (34%) Claim depth 12.5 pts (28%)

Qualcomm Incorporated · highest

85
Danfoss Power… · near

45
CaaStle · near

45
Debiotech · this assignee

45
Kuka Roboter · near

45
Poclain Hydraulics… · near

45
3D Lighting… · lowest

7

What this shows Debiotech's Innovation Score is 45.5/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Debiotech?

Each dot is one of Debiotech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Debiotech’s own 20.9 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Debiotech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Debiotech's grants concentrate

Debiotech S.A. is a focused PatentsView assignee: 19 CPC subclasses with 92.6% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2018 (10 grants) versus a trough of 1 in 2023. By volume, Debiotech sits between Comau S.p.A. and Expro North SEA Limited.

Debiotech's three-year grant acceleration

Debiotech S.A. shows 10 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Comau S p A

54
Constellation Pha…

54
Dai-ichi Kogyo Se…

54
DAS

54
Distech Controls

54
Delta (Thailand)…

54
Easebon Services

54
Expro North SEA

54
Debiotech ◀

54

What this shows Debiotech holds 54 patents at rank #6,233, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Debiotech

By rank, the assignees closest to #6,233 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Debiotech's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Debiotech, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Debiotech ranks #145 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

CaaStle, Inc 45 Poclain Hydraulics Industrie 45 Kuka Roboter GmbH 45 Danfoss Power Solutions GMBH & Co. OHG 45

Similar claim depth

Nearest assignees by average claims per patent (20.9 here).

Imperva, Inc. 20.9 avg FMR LLC 20.9 avg Kymab Limited 20.8 avg STMicroelectronics Application GMBH 20.9 avg

Debiotech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Debiotech S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	9.3%
2016	7	13.0%
2017	4	7.4%
2018	10	18.5%
2019	6	11.1%
2020	6	11.1%
2021	6	11.1%
2022	4	7.4%
2023	1	1.9%
2024	5	9.3%

Which technologies does Debiotech S.A. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 50

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 10

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 10

F04D - Non-positive-displacement Pumps 6

Y10T - Technical Subjects Covered BY Former US Classification 6

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 4

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 3

B81C - Processes OR Apparatus Specially Adapted FOR THE Manufacture OR Treatment OF Microstructural Devices OR Systems 3

F15B - Systems Acting BY Means OF Fluids IN GENERAL; Fluid-pressure Actuators, e.g. SERVOMOTORS; Details OF Fluid-pressure Systems, NOT Otherwise Provided FOR 2

G06F - Electric Digital Data Processing 2

G05D - Systems FOR Controlling OR Regulating Non-electric Variables 2

A61B - DIAGNOSIS; SURGERY; Identification 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Debiotech S.A.'s patent record in context - here's where to go next.

Debiotech S.A.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 92.6% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #6,233 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Debiotech S.A. against Comau S.p.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.